Your browser doesn't support javascript.
loading
Investigating DWI changes in white matter of meningioma patients treated with proton therapy.
Buizza, Giulia; Zampini, Marco Andrea; Riva, Giulia; Molinelli, Silvia; Fontana, Giulia; Imparato, Sara; Ciocca, Mario; Iannalfi, Alberto; Orlandi, Ester; Baroni, Guido; Paganelli, Chiara.
Afiliação
  • Buizza G; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy. Electronic address: giulia.buizza@polimi.it.
  • Zampini MA; MR Solutions Ltd., Ashbourne House, Old Portsmouth Rd., Guildford, United Kingdom. Electronic address: marco.zampini@mrsolutions.com.
  • Riva G; Clinical Department, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: giulia.riva@cnao.it.
  • Molinelli S; Medical Physics Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: silvia.molinelli@cnao.it.
  • Fontana G; Clinical Bioengineering Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: giulia.fontana@cnao.it.
  • Imparato S; Radiology Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: sara.imparato@cnao.it.
  • Ciocca M; Medical Physics Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: mario.ciocca@cnao.it.
  • Iannalfi A; Clinical Department, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: alberto.iannalfi@cnao.it.
  • Orlandi E; Clinical Department, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: ester.orlandi@cnao.it.
  • Baroni G; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy; Clinical Bioengineering Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi 53, 27100 Pavia, Italy. Electronic address: guido.baroni@polimi.it.
  • Paganelli C; Department of Electronics, Information and Bioengineering, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milan, Italy. Electronic address: chiara.paganelli@polimi.it.
Phys Med ; 84: 72-79, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33872972
PURPOSE: To evaluate changes in diffusion and perfusion-related properties of white matter (WM) induced by proton therapy, which is capable of a greater dose sparing to organs at risk with respect to conventional X-ray radiotherapy, and to eventually expose early manifestations of delayed neuro-toxicities. METHODS: Apparent diffusion coefficient (ADC) and IVIM parameters (D, D* and f) were estimated from diffusion-weighted MRI (DWI) in 46 patients affected by meningioma and treated with proton therapy. The impact on changes in diffusion and perfusion-related WM properties of dose and time, as well as the influence of demographic and pre-treatment clinical information, were investigated through linear mixed-effects models. RESULTS: Decreasing trends in ADC and D were found for WM regions hit by medium-high (30-40 Gy(RBE)) and high (>40 Gy(RBE)) doses, which are compatible with diffusion restriction due to radiation-induced cellular injury. Significant influence of dose and time on median ADC changes were observed. Also, D* showed a significant dependency on dose, whereas f consistently showed no dependency on dose and time. Age, gender and surgery extent were also found to affect changes in ADC. CONCLUSIONS: These results overall agree with those from studies conducted on cohorts of mixed proton and X-ray radiotherapy patients. Future work should focus on relating our findings with clinical information of co-morbidities and thus exploiting such or more advanced imaging data to build normal tissue complication probability models to better integrate clinical and dose information.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia com Prótons / Substância Branca / Neoplasias Meníngeas / Meningioma Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia com Prótons / Substância Branca / Neoplasias Meníngeas / Meningioma Idioma: En Ano de publicação: 2021 Tipo de documento: Article